Thompson, George - University of California, Davis - Department of Medical Microbiology and Immunology

研究领域

Dr. Thompson is Associate Professor of Clinical Medicine at the University of California, Davis, School of Medicine with a joint appointment in the Departments of Medical Microbiology and Immunology, and Internal Medicine, Division of Infectious Diseases. Dr. Thompson specializes in the care of patients with invasive fungal infections and has research interest in fungal diagnostics and host immunogenetics. His current research focuses on the host-pathogen interaction of humans and both Coccidioides spp. (the agent of “Valley Fever”), and Cryptococcus spp. Dr. Thompson has served on the IDSA Journal Club which is a committee comprised of 12 panelists who select key papers for review and compose a summary of important articles that is published in the internationally disseminated monthly IDSA News. Additionally, he is a member of the Coccidioidomycosis Study Group Planning Committee, and as Co-chair of the Mycoses Study Group - a committee responsible for the development of content and dissemination of materials to practitioners across the United States, planning of the mycology content at our yearly meetings (IDSA and ICAAC), and the design of clinical trials.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Thompson GR III, Kontoyiannis DP, Patterson TF. Management of an Outbreak: Real-World experience in the midst of an Exserohilum meningitis outbreak. Journal of the American Medical Association (JAMA). 2013; Jun 19;309(23):2493-5. PMID: 23780464 Brown J, Benedict K, Park BJ, Thompson GR III. Coccidioidomycosis: epidemiology. Clinical Epidemiology. 2013:5 185–197. PMID: 23843703 Thompson GR III, Wang S, Bercovitch R, Bolaris M, Akker DVD, Taylor S, Lopez R, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B. Routine CSF Analysis in Coccidioidomycosis is Not Required. PLOS One. 2013; May 21;8(5):e64249; 1-5. PMID: 23717579 Sharma S, Thompson GR III. How I Treat Coccidioidomycosis. Current Fungal Infection Reports. 2013; 7(1):29-35. Marsden-Haug N, Goldoft M, Ralston C, Limaye AP, Chua J, Hill H, Jecha L, Thompson GR III, Chiller T. Coccidioidomycosis Acquired in Washington State. Clinical Infectious Diseases. 2013 Mar;56(6):847-50. PMID: 23223598 Thompson GR III, Sharma S, Bays DJ, Pruitt R, Engelthaler DM, Bowers J, Driebe EM, Davis M, Libke R, Cohen SH, Pappagianis D. Pleural Effusions Caused by Coccidioidomycosis: ADA levels, serologic parameters, culture results and PCR testing. CHEST. 2013 Mar;143(3):776-81. PMID: 23187746 Chang C, Gershwin E, Thompson GR III. Fungal Disease of the Nose and Sinuses: An Updated Overview. Current Allergy and Asthma Reports. 2013 Apr;13(2):152-61. PMID: 23135919 Thompson GR III, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA. D. Serum (1®3)-β-D-Glucan Measurement in Coccidioidomycosis. Journal of Clinical Microbiology. 2012 Sep;50(9):3060-2. PMID: 22692738 Thompson GR III, Bays DJ, Taylor SL, Cohen SH, Pappagianis D. Association Between Serum 25-Hydroxyvitamin D Level and Type of Coccidioidal Infection. Medical Mycology. 2013 Apr;51(3):319-23. PMID: 22680977 Thompson GR III, Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Graybill DR, Patterson TF. A Murine Model of Cryptococcus gattii Meningoencephalitis. Journal of Antimicrobial Chemotherapy. 2012 Jun;67(6):1432-8. PMID: 22378683 Thompson GR III. Strategies to Combat Coccidioidomycosis: Are We Making Any Progress? Current Fungal Infection Reports. 2011; 5:215–223 Thompson GR III, Patterson TF. Fungal disease of the nose and paranasal sinuses. Journal of Allergy and Clinical Immunology. 2012; Feb; 129(2):321-6. PMID: 22206776 Thompson GR III. Pulmonary Coccidioidomycosis. Respiratory and Critical Care Medicine. 2011; Dec;32(6):754-63. PMID: 22167403 Thompson GR III, Patterson TF. Pulmonary Aspergillosis: Recent Advances. Respiratory and Critical Care Medicine. 2011; Dec;32(6):673-81. PMID: 22167395 Thompson GR III, Bays D, Cohen SH, Pappagianis D. Fluoride Excess in Coccidioidomycosis Patients Receiving Long-Term Antifungal Therapy: An assessment of currently available triazoles. Antimicrobial Agents and Chemotherapy. 2012 Jan;56(1):563-4. PMID: 22005993 Thompson GR III, Lunetta JM, Johnson SM, Taylor S, Bays D, Cohen SH, Pappagianis D. Early Treatment with Fluconazole may Abrogate the Development of IgG Antibodies in Coccidioidomycosis. Clinical Infectious Diseases. 2011; Sep;53(6):e20-4. PMID: 21865185